Brief: Vyne Therapeutics Reports First Quarter 2023 Financial Results

YARROW BIOSCIENCE

11/05/2023 21:47

May 11 (Reuters) - Vyne Therapeutics Inc  VYNE.O :
    * VYNE THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
    * VYNE THERAPEUTICS INC - REVENUES FOR QUARTER ENDED MARCH
31,
2023 WERE $0.1 MILLION
    * VYNE THERAPEUTICS INC - NET LOSS AND NET LOSS PER SHARE
FOR
QUARTER ENDED MARCH 31, 2023 WAS $5.6 MILLION AND $1.74,
RESPECTIVELY
    * VYNE THERAPEUTICS INC - QTRLY LOSS PER SHARE $1.74

Source text for Eikon:  ID:nGNX2GLrVq 
Further company coverage:  VYNE.O 

 ((Reuters.Briefs@thomsonreuters.com;))